Related Experiment Videos
[Rift Valley fever virus].
Tetsuro Ikegami1, Shinji Makino
1Department of Microbiology and Immunology, University of Texas Medical Branch, Medical Research Building, 301 University Blvd., Galveston, Texas 77555-1019, USA.
Uirusu
|March 5, 2005
Summary
Rift Valley fever virus (RVFV) causes severe epidemics in humans and livestock. Developing a reverse genetics system is crucial for understanding RVFV replication and creating vaccines.
Area of Science:
- Virology
- Molecular Biology
- Epidemiology
Context:
- Rift Valley fever virus (RVFV) is a mosquito-borne pathogen endemic to sub-Saharan Africa.
- RVFV causes significant morbidity and mortality in humans (hemorrhagic fever, encephalitis) and livestock (10-30% mortality in ruminants).
- Virus transmission is facilitated by the presence of susceptible hosts (sheep, cattle) and mosquito vectors.
Purpose:
- To highlight the importance of developing a reverse genetics system for RVFV.
- To underscore the need for further research into viral replication and pathogenesis.
- To facilitate vaccine development and evaluation.
Summary:
- RVFV is a negative-strand RNA virus with a tripartite genome, belonging to the Bunyaviridae family.
- The NSs protein of RVFV inhibits host mRNA synthesis by binding to transcription factor TFIIH, leading to host protein shut-off.
- A functional reverse genetics system for RVFV is currently lacking but essential for comprehensive study.
Impact:
- Enables detailed investigation of RVFV replication mechanisms.
- Facilitates understanding of host-virus interactions and viral pathogenicity.
- Crucial for the development and efficacy testing of RVFV vaccines.